| scholarly article | Q13442814 |
| P2093 | author name string | Kosten TR | |
| Jacobsen LK | |||
| Staley JK | |||
| Innis RB | |||
| Malison RT | |||
| Seibyl JP | |||
| Zoghbi SS | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | serotonin | Q167934 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 1134-1140 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients | |
| P478 | volume | 157 |
| Q36740524 | 123I-ADAM SPECT imaging of serotonin transporter binding in patients with night eating syndrome: a preliminary report |
| Q37352917 | Abstinence from chronic cocaine self-administration alters striatal dopamine systems in rhesus monkeys |
| Q51388378 | Age-related decline in central serotonin transporter availability with [(123)I]beta-CIT SPECT. |
| Q43299756 | Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study |
| Q36481299 | Animal models of drug addiction: Where do we go from here? |
| Q33841432 | Aripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humans |
| Q44317390 | Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration |
| Q46691558 | Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder |
| Q34466444 | Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems |
| Q35839390 | Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. |
| Q21198902 | Depression research: where are we now? |
| Q35017128 | Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys |
| Q43744877 | Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. |
| Q36930260 | Dopamine transporter levels in cocaine dependent subjects |
| Q38207705 | Drugs currently in Phase II clinical trials for cocaine addiction |
| Q36312733 | Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys |
| Q44693601 | Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder |
| Q34558846 | How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? |
| Q33930038 | Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopy |
| Q37140457 | Imaging receptor changes in human drug abusers |
| Q33652554 | Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels |
| Q30413718 | Monoamine transporter inhibitors and substrates as treatments for stimulant abuse |
| Q43685941 | Neuroendocrine effects of d-fenfluramine and bromocriptine following repeated smoked cocaine in humans |
| Q36314030 | Neuroreceptor imaging in psychiatry: theory and applications. |
| Q26829186 | Pharmacotherapy for stimulant-related disorders |
| Q37049887 | Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder |
| Q44071086 | Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures |
| Q42652057 | Reboxetine for the treatment of patients with Cocaine Dependence Disorder |
| Q35910290 | Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders |
| Q42325301 | Reduced forebrain serotonin transmission is causally involved in the development of compulsive cocaine seeking in rats |
| Q44380074 | Relationship between platelet serotonin uptake sites and treatment outcome among African-American cocaine dependent individuals |
| Q28258373 | Relationship of prolactin response to meta-chlorophenylpiperazine with severity of drug use in cocaine dependence |
| Q33980834 | SPECT imaging with the serotonin transporter radiotracer [123I]p ZIENT in nonhuman primate brain |
| Q44318183 | Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers |
| Q44179074 | Self-rated childhood emotional neglect and CSF monoamine indices in abstinent cocaine-abusing adults: possible implications for suicidal behavior |
| Q27015917 | Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder |
| Q45006432 | Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder |
| Q34942640 | Serotonin and mental disorders: a concise review on molecular neuroimaging evidence |
| Q44022970 | Serotonin transporter polymorphisms and measures of impulsivity, aggression, and sensation seeking among African-American cocaine-dependent individuals |
| Q46713916 | Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle |
| Q44270029 | The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure |
| Q34435130 | The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders |
| Q48326056 | [123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers |
Search more.